{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:03:41Z","timestamp":1746709421990},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00108-024-01775-3","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T11:06:59Z","timestamp":1726225619000},"page":"999-1008","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Eine STI kommt selten allein\u00a0\u2013 sexuell \u00fcbertragbare Infektionen im \u00dcberblick","An STI rarely comes alone\u2014An overview of sexually transmitted infections"],"prefix":"10.1007","volume":"65","author":[{"given":"Carola","family":"Horn-Magar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"1775_CR1","unstructured":"https:\/\/www.ecdc.europa.eu\/en\/news-events\/sti-cases-rise-across-europe. Zugegriffen: 1. M\u00e4rz 2024"},{"key":"1775_CR2","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s00103-017-2590-1","volume":"60","author":"V Bremer","year":"2017","unstructured":"Bremer\u00a0V, Dudareva-Vizule\u00a0S, Buder\u00a0S et\u00a0al (2017) Sexuell \u00fcbertragbare Infektionen in Deutschland. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 60:948\u2013957","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"1775_CR3","unstructured":"AWMF (2016) Infektionen mit Chlamydia trachomatis. https:\/\/register.awmf.org\/assets\/guidelines\/059-005l_S2k_Chlamydia-trachomatis_Infektionen_2016-12-abgelaufen.pdf. Zugegriffen: 15. Jan. 2024"},{"issue":"3","key":"1775_CR4","first-page":"241","volume":"11","author":"S Abraham","year":"2013","unstructured":"Abraham\u00a0S, Poehlmann\u00a0C, Spornraft-Ragaller\u00a0P (2013) Gonorrhea: data on antibiotic resistance and accompanying infections at the university hospital Dresden over a\u00a010-year time period. J\u00a0Dtsch Dermatol Ges 11(3):241\u2013249","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"1775_CR5","unstructured":"AWMF (2018) Diagnotik und Therapie der Gonorrhoe. https:\/\/register.awmf.org\/assets\/guidelines\/059-004l_S2k_Gonorrhoe-Diagnostik-Therapie_2019-03.pdf. Zugegriffen: 15. Jan. 2024"},{"key":"1775_CR6","unstructured":"https:\/\/www.ecdc.europa.eu\/en\/publications-data\/gonococcal-antimicrobial-susceptibility-surveillance-eu-eea. Zugegriffen: 27. Juni 2024"},{"key":"1775_CR7","unstructured":"https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Merkblaetter\/Ratgeber_Gonorrhoe.html#doc3763050bodyText9. Zugegriffen: 11. Juni 2024"},{"issue":"9","key":"1775_CR8","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s40121-023-00862-6","volume":"12","author":"C Perry","year":"2023","unstructured":"Perry\u00a0C, Scangarella-Oman\u00a0N, Millns\u00a0H et\u00a0al (2023) Efficacy and safety of gepotidacin as treatment of uncomplicated urogenital gonorrhea (EAGLE-1): design of a\u00a0randomized, comparator-controlled, phase\u00a03 study. Infect Dis Ther 12(9):2307\u20132320","journal-title":"Infect Dis Ther"},{"key":"1775_CR9","unstructured":"AWMF (2021) Diagnostik und Therapie der Syphilis. https:\/\/register.awmf.org\/assets\/guidelines\/059-002l_S2k_Diagnostik_Therapie_Syphilis_2021_06.pdf. Zugegriffen: 18. Jan. 2024"},{"key":"1775_CR10","unstructured":"https:\/\/asm.org\/articles\/2020\/january\/a-brief-history-of-laboratory-diagnostics-for-syph. Zugegriffen: 1. Mai 2024"},{"key":"1775_CR11","first-page":"330","volume-title":"Klinikleitfaden Infektiologie","author":"S Esser","year":"2021","unstructured":"Esser\u00a0S (2021) Sexuell \u00fcbertragbare Infektionen. In: Jung\u00a0N, Rieg\u00a0S, Lehmann\u00a0C (Hrsg) Klinikleitfaden Infektiologie. Elsevier, M\u00fcnchen, S\u00a0330\u2013333"},{"key":"1775_CR12","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7004a1","author":"K Workowski","year":"2021","unstructured":"Workowski\u00a0K, Bachmann\u00a0L, Chan\u00a0P (2021) Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. https:\/\/doi.org\/10.15585\/mmwr.rr7004a1","journal-title":"MMWR Recomm. Rep."},{"key":"1775_CR13","first-page":"466","volume":"22","author":"R Werner","year":"2024","unstructured":"Werner\u00a0R, Schmidt\u00a0A, Potthoff\u00a0A et\u00a0al (2024) Position statement of the German STI Society on the prophylactic use of doxycycline to prevent STIs (Doxy-PEP, Doxy-Prep). J\u00a0Dtsch Dermatol Ges 22:466\u2013478","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"1775_CR14","unstructured":"Die Zahl der Menschen mit und die Kenntnis von Infektionsrisiken. https:\/\/www.rki.de\/DE\/Content\/Service\/Presse\/Pressemitteilungen\/2022\/08_2022. Zugegriffen: 15. Jan. 2024"},{"key":"1775_CR15","first-page":"3","volume":"48","author":"M an der Heiden","year":"2020","unstructured":"an der Heiden\u00a0M, Marcus\u00a0U, Kollan\u00a0C et\u00a0al (2020) Sch\u00e4tzung der Zahl der HIV-Neuinfektionen und der Gesamtzahl von Menschen mit HIV in Deutschland, Stand Ende 2019. Epidemiol Bull 48:3\u201316","journal-title":"Epidemiol Bull"},{"key":"1775_CR16","unstructured":"DAIG (2020) Deutsch-\u00d6sterreichische Leitlinien zur antitretroviralen Therapie der HIV\u20111 Infektion. https:\/\/register.awmf.org\/assets\/guidelines\/055-001l_Antiretrovirale_Therapie_der_HIV_Infektion__2021-06.pdf. Zugegriffen: 15. Jan. 2024"},{"issue":"1","key":"1775_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.2022.22246","volume":"329","author":"R Gandhi","year":"2023","unstructured":"Gandhi\u00a0R, Bedimo\u00a0R, Hoy\u00a0J et\u00a0al (2023) Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the international antiviral society-USA panel. JAMA 329(1):63\u201384","journal-title":"JAMA"},{"key":"1775_CR18","unstructured":"DAIG (2018) Deutsch-\u00d6sterreichische Leitlinien zur HIV-Pr\u00e4expositionsprophylaxe. https:\/\/register.awmf.org\/assets\/guidelines\/055-008l_S2k_HIV-Praeexpositionsprophylaxe_2019-01_01.pdf. Zugegriffen: 15. Jan. 2024"},{"key":"1775_CR19","unstructured":"Epidemiologisches Bulletin 29\/2022 rki.de"},{"key":"1775_CR20","unstructured":"https:\/\/www.cdc.gov\/poxvirus\/mpox\/outbreak\/2023-drc.html. Zugegriffen: 27. Juni 2024"},{"key":"1775_CR21","unstructured":"https:\/\/www.rki.de\/DE\/Content\/Infekt\/Impfen\/ImpfungenAZ\/Affenpocken\/STIKO-Stellungnahme-MVA-intradermal.html. Zugegriffen: 1. Apr. 2024"},{"key":"1775_CR22","doi-asserted-by":"publisher","DOI":"10.1055\/a-0655-5660","author":"Robert-Koch-Institut","year":"2018","unstructured":"Robert-Koch-Institut (2018) Wissenschaftliche Begr\u00fcndung f\u00fcr die Empfehlung der HPV-Impfung f\u00fcr Jungen im Alter von 9\u00a0bis 14\u00a0Jahren. Epidemiol Bull. https:\/\/doi.org\/10.1055\/a-0655-5660","journal-title":"Epidemiol Bull"},{"issue":"6","key":"1775_CR23","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/jnci\/djad263","volume":"116","author":"T Palmer","year":"2024","unstructured":"Palmer\u00a0T, Kavanagh\u00a0K, Cuschieri\u00a0K et\u00a0al (2024) Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a\u00a0population-based observational study of age at immunization, dose, and deprivation. JNCIJ 116(6):857\u2013865","journal-title":"JNCIJ"},{"key":"1775_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1136\/sextrans-2023-055793","volume":"99","author":"M Petr\u00e1\u0161","year":"2023","unstructured":"Petr\u00e1\u0161\u00a0M, Dvo\u0159\u00e1k\u00a0V, Lomozov\u00e1\u00a0D et\u00a0al (2023) Timing of HPV vaccination as adjuvant treatment of CIN2+ recurrence in women undergoing surgical excision: a\u00a0meta-analysis and meta-regression. Sex Transm Infect 99:561\u2013570","journal-title":"Sex Transm Infect"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01775-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-024-01775-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01775-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T10:02:39Z","timestamp":1728036159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-024-01775-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1775"],"URL":"https:\/\/doi.org\/10.1007\/s00108-024-01775-3","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"type":"print","value":"2731-7080"},{"type":"electronic","value":"2731-7099"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"assertion":[{"value":"25 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>C.\u00a0Horn-Magar<\/b>: A.\u00a0Finanzielle Interessen: Referentinnenhonorar und Kostenerstattung durch MSD 2022, Referentinnenhonorar Akademie f\u00fcr Infektionsmedizin Spring School K\u00f6ln 2023, 2024. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Assistenz\u00e4rztin f\u00fcr Innere Medizin und Infektiologie, Uniklinik K\u00f6ln | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Innere Medizin (DGIM), Deutsche Gesellschaft f\u00fcr Infektiologie (DGI). Deutsche Gesellschaft f\u00fcr Tropenmedizin, Reisemedizin und Globale Gesundheit e.\u202fV. <b>C.\u00a0Lehmann<\/b>: A.\u00a0Finanzielle Interessen: Deutsches Zentrum f\u00fcr Infektionsforschung (DZIF), Bundesministerium f\u00fcr Bildung und Forschung (BMBF).\u00a0\u2013 Fahrtkosten, Hotel: Gilead, Conference on Retroviruses and Opportunistic Infections (CROI). \u2013\u00a0Die Institution von C. Lehmann wird noch ausstehende F\u00f6rdermittel von Gilead erhalten. C.\u00a0Lehmann ber\u00e4t wissenschaftlich ViiV Healthcare, Gilead Sciences, Pfizer, Inc, Novartis, BioNTech und MSD.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin, Universit\u00e4tsklinikum K\u00f6ln, Klinik f\u00fcr Innere Medizin, Klinische Infektiologie | Mitgliedschaften: DGIM, DGI, Vorstand Akademie f\u00fcr Infektionsmedizin, Deutsche AIDS-Gesellschaft (DAIG).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}